Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,896Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 16Jardiance

02 1jardiance

PharmaCompass

01

Brand Name : Jardiance

Empagliflozin

arrow
AGGSpend
Not Confirmed

02

Brand Name : Jardiance

Empagliflozin

arrow
AGGSpend
Not Confirmed

Brand Name : Jardiance

arrow
AGGSpend
Not Confirmed

Empagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 1,154

2019 Revenue in Millions : 944

Growth (%) : 22

blank

03

Brand Name : Jardiance

Empagliflozin

arrow
AGGSpend
Not Confirmed

04

Brand Name : Jardiance

Empagliflozin

arrow
AGGSpend
Not Confirmed

Brand Name : Jardiance

arrow
AGGSpend
Not Confirmed

Empagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2021 Revenue in Millions : 1,491

2020 Revenue in Millions : 1,154

Growth (%) : 29

blank

05

Brand Name : Jardiance

Empagliflozin

arrow
AGGSpend
Not Confirmed

06

Brand Name : Jardiance

Empagliflozin

arrow
AGGSpend
Not Confirmed

Brand Name : Jardiance

arrow
AGGSpend
Not Confirmed

Empagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2022 Revenue in Millions : 2,066

2021 Revenue in Millions : 1,491

Growth (%) : 39

blank

07

Brand Name : Jardiance

Empagliflozin

arrow
AGGSpend
Not Confirmed

08

Brand Name : Jardiance

Empagliflozin

arrow
AGGSpend
Not Confirmed

Brand Name : Jardiance

arrow
AGGSpend
Not Confirmed

Empagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2023 Revenue in Millions : 2,745

2022 Revenue in Millions : 2,066

Growth (%) : 33

blank

09

Brand Name : Jardiance

Empagliflozin

arrow
AGGSpend
Not Confirmed

Brand Name : Jardiance

arrow
AGGSpend
Not Confirmed

Empagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2024 Revenue in Millions : 3,341

2023 Revenue in Millions : 2,745

Growth (%) : 22

blank

10

Brand Name : Jardiance

Empagliflozin

arrow
AGGSpend
Not Confirmed